Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 778.30
+1.30 (0.17%)
Feb 18, 2026, 12:00 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 152.73 billion as of February 17, 2026. Its market cap has decreased by -14.50% in one year.
Market Cap
152.73B
Enterprise Value
166.15B
Revenue
72.67B
Ranking
n/a
PE Ratio
24.23
Stock Price
778.30
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 152.73B, an increase of 1,596.69%. That is a compound annual growth rate of 21.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 152.73B | -8.17% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 293.40B |
| Emcure Pharmaceuticals | 282.22B |
| Wockhardt | 225.88B |
| Piramal Pharma | 220.36B |
| Eris Lifesciences | 189.00B |
| NATCO Pharma | 147.56B |
| Cohance Lifesciences | 120.74B |
| Alivus Life Sciences | 110.62B |